New inhaler drug HRS-9821 enters first human tests for COPD
NCT ID NCT07116915
First seen Nov 01, 2025 · Last updated May 06, 2026 · Updated 32 times
Summary
This early-stage study tests a new inhaled medicine called HRS-9821 in 160 people. First, healthy volunteers get a single dose to check safety. Then, people with COPD take multiple doses to see if it helps control their condition. The main goal is to find out if the drug is safe and tolerable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
West China Hospital, Sichuan University
RECRUITINGChengdu, Sichuan, 610044, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.